In the evolving landscape of cannabis law, Joshua Bauchner, Chair of the Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, has recently been spotlighted in the weekly article of the International Society of Primerus Law Firms. Read the Primerus article, here.
Joshua Bauchner stands out in the emerging cannabis law field, noting the irony of leading in an industry centered on a plant known for millennia. He offers legal guidance to a wide range of clients in the cannabis sector, tackling the intricate legal and regulatory framework. Bauchner’s entry into cannabis law began with his involvement with High Times magazine, leading to significant legal actions, such as averting the shutdown of the 2017 High Times Cannabis Cup by federal authorities. This marked the beginning of his deep involvement in cannabis law.
Bauchner’s career is highlighted by his proactive stance on cannabis legalization and his efforts to educate businesses on navigating the industry’s legal landscape. His leadership in cannabis law was further solidified through the hosting of the 1st Annual Cannabis Symposium, which attracted an unexpectedly large audience, underscoring the growing interest and demand for legal guidance in this area. His journey from being predicted to become a lawyer due to his argumentative nature as a child to becoming a prominent figure in cannabis law underscores his dedication and enthusiasm for the field.
His work also extends to psychedelics, pushing the boundaries of legal practice to include new areas of law. Bauchner’s contributions to the field have been recognized with awards, and he strongly believes in the potential of natural substances like cannabis and psilocybin for medicinal purposes, anticipating significant cultural and medicinal impacts from their legalization and research. Bauchner’s career not only reflects his legal skills but also his commitment to advancing the understanding and acceptance of cannabis and psychedelics in society.
Find out more about Joshua and our Cannabis, Hemp, and Psychedelics Practice Group, here.